Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyrotinib, Trastuzumab, and AI in HER2+/HR+ Advanced Breast Cancer
NCT04088110Phase 2Unknown
- Sponsor
- 900th Hospital of Joint Logistics Support Force of PLA
- Start
- Nov 2019
- Primary completion
- Nov 2021
- Countries
- 1
01
Overview
A Phase 2 trial of pyrotinib in breast cancer, sponsored by 900th Hospital of Joint Logistics Support Force of PLA. Status: unknown.
02
Drugs
pyrotinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04088110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04088110.